Literature DB >> 15059025

Cryosurgery for tumors - a clinical overview.

Andrew A Gage1, John G Baust.   

Abstract

Cryosurgery, a method of treating disease by the production of freezing temperatures in the tissue, is a useful technique for the treatment of tumors. When the modern era of cryosurgery began in the mid 1960's, the technique was used only for tumors easily accessible by direct observation or via endoscopy, such as those of the skin, oral cavity, and prostate gland. In general, the technique had limited usefulness in the next two decades. However, with the advent of intraoperative ultrasound as a method of monitoring the process of freezing and with the development of more effective cryosurgical apparatus, the cryosurgical treatment of tumors of the viscera and other deep tissues became practical in the 1990's. This review assesses the present day status of cryosurgery in the management of diverse tumors.

Entities:  

Mesh:

Year:  2004        PMID: 15059025     DOI: 10.1177/153303460400300212

Source DB:  PubMed          Journal:  Technol Cancer Res Treat        ISSN: 1533-0338


  13 in total

1.  Vitamin D(3) cryosensitization increases prostate cancer susceptibility to cryoablation via mitochondrial-mediated apoptosis and necrosis.

Authors:  John M Baust; Daniel P Klossner; Anthony Robilotto; Robert G Vanbuskirk; Andrew A Gage; Vladimir Mouraviev; Thomas J Polascik; John G Baust
Journal:  BJU Int       Date:  2011-08-26       Impact factor: 5.588

2.  "Finger-tip" cryotherapy probes: treatment of squamous and melanocytic conjunctival neoplasia.

Authors:  P T Finger
Journal:  Br J Ophthalmol       Date:  2005-08       Impact factor: 4.638

3.  Effects of freezing on intratumoral drug transport.

Authors:  Bumsoo Han; Ka Yaw Teo
Journal:  Conf Proc IEEE Eng Med Biol Soc       Date:  2009

4.  Characterization of Pancreatic Cancer Cell Thermal Response to Heat Ablation or Cryoablation.

Authors:  Kenneth W Baumann; John M Baust; Kristi K Snyder; John G Baust; Robert G Van Buskirk
Journal:  Technol Cancer Res Treat       Date:  2016-06-23

5.  Use of 1,25α dihydroxyvitamin D3 as a cryosensitizing agent in a murine prostate cancer model.

Authors:  K L Santucci; K K Snyder; J M Baust; R G Van Buskirk; V Mouraviev; T J Polascik; A A Gage; J G Baust
Journal:  Prostate Cancer Prostatic Dis       Date:  2011-01-11       Impact factor: 5.554

6.  Integrin involvement in freeze resistance of androgen-insensitive prostate cancer.

Authors:  J G Baust; D P Klossner; R G Vanbuskirk; A A Gage; V Mouraviev; T J Polascik; J M Baust
Journal:  Prostate Cancer Prostatic Dis       Date:  2010-01-12       Impact factor: 5.554

7.  Evaluation of a novel cryoablation system: in vitro testing of heat capacity and freezing temperatures.

Authors:  Timo Weimar; Anson M Lee; Shuddhadeb Ray; Richard B Schuessler; Ralph J Damiano
Journal:  Innovations (Phila)       Date:  2012 Nov-Dec

8.  Assessment of Cryosurgical Device Performance Using a 3D Tissue-Engineered Cancer Model.

Authors:  John M Baust; Anthony Robilotto; Kristi K Snyder; Kimberly Santucci; Jennie Stewart; Robert Van Buskirk; John G Baust
Journal:  Technol Cancer Res Treat       Date:  2017-05-17

9.  Computational study of the effects of arterial bifurcation on the temperature distribution during cryosurgery.

Authors:  Yong-Chang Zheng; Jun-Hong Wu; Zhi-Zhu He; Shao-Jiong Huang
Journal:  Biomed Eng Online       Date:  2018-01-16       Impact factor: 2.819

10.  Assessment of a novel cryoablation device for the endovascular treatment of cardiac tachyarrhythmias.

Authors:  John M Baust; Anthony Robilotto; Peter Guerra; Kristi K Snyder; Robert G Van Buskirk; Marc Dubuc; John G Baust
Journal:  SAGE Open Med       Date:  2018-05-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.